MedTrace Logo

Effectiveness and Safety of Berberine Hydrochloride and Bifidobacterium in People With Abnormal Glucose Level

NCT03330184 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 300

Last updated 2021-03-15

No results posted yet for this study

Summary

The aim of this study is to assess the beneficial effects of Bifidobacterium and Berberine Hydrochloride on lowering glucose and delaying progress to diabetes in patients with prediabetes and to detect the potential mechanism.

Conditions

  • Berberine Hydrochloride

Interventions

DRUG

Berberine Hydrochloride group

DRUG

Bifidobacterium group

DRUG

Berberine Hydrochloride and Bifidobacterium group

DRUG

placebo

Sponsors & Collaborators

  • Second Affiliated Hospital of Xi'an Jiaotong University

    collaborator OTHER

  • Yan'an University Affiliated Hospital

    collaborator OTHER

  • Shaanxi Aerospace Hospital

    collaborator UNKNOWN

  • Genertec Universal Xi'an Aero-Engine hospital (Xi' an) Co., Ltd

    collaborator UNKNOWN

  • Xi'an Gaoxin Hospital

    collaborator OTHER

  • Chang'An Hospital

    collaborator OTHER

  • Xi'an Central Hospital

    collaborator OTHER

  • Yan'an people's Hospital

    collaborator UNKNOWN

  • Shangluo Central Hospital

    collaborator OTHER

  • Xijing Hospital

    lead OTHER

Principal Investigators

  • Qiuhe Ph.D. Ji, M.D. · Department of Endocrinology,Xi jing Hospital,Fourth Military Medical University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-10-31
Primary Completion
2018-04-30
Completion
2018-04-30

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03330184 on ClinicalTrials.gov